Starsource Multitrade Ltd (CHEMOPH) is currently trading at 80.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Chemo Pharma Laboratories Ltd., established in 1942, originally operated in pharmaceuticals, producing bulk drugs. Due to heightened competition, Chemo Pharma exited its pharmaceutical business, paying down liabilities completely. The company currently possesses its own cash resources and is strategically planning diversification and acquisitions. Chemo Pharma is negotiating the acquisition of a sick company with promising prospects in the Power and Chemicals sectors. The successful acquisition and rehabilitation could significantly alter the company's business model.

Over the past 52 weeks, Starsource Multitrade Ltd has traded between a low of ₹70.01 and a high of ₹152.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Starsource Multitrade Ltd has a market capitalization of approximately 11.57. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Starsource Multitrade Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -289.25 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 11.57 Cr, Starsource Multitrade Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Starsource Multitrade Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Starsource Multitrade Ltd is -289.25. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.